Exercise bouts could improve efficacy of cancer drug
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukaemia, new research has shown.
Stay updated with breaking news from Brain Behaviour. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukaemia, new research has shown.
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.
Tokyo, May 31: Autoantibodies, or immune system-produced proteins that may function against one's own body, have been linked to reports of schizophrenia. A minority of schizophrenia patients had autoantibodies that targeted neurexin 1, a synaptic adhesion protein, according to a study published last month in Brain Behaviour and Immunity. The autoantibodies led to numerous schizophrenia-related alterations when administered to animals.
Autoantibodies, or immune system-produced proteins that may function against one's own body, have been linked to reports of schizophrenia
New study finds that the gut microbiome has a role in driving differences in pain sensation between men and women.